Activest Wealth Management Has $124,000 Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Activest Wealth Management trimmed its position in iShares Biotechnology ETF (NASDAQ:IBB) by 35.4% in the third quarter, HoldingsChannel.com reports. The firm owned 852 shares of the financial services provider’s stock after selling 467 shares during the period. Activest Wealth Management’s holdings in iShares Biotechnology ETF were worth $124,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Blue Fin Capital Inc. grew its holdings in shares of iShares Biotechnology ETF by 0.7% in the 2nd quarter. Blue Fin Capital Inc. now owns 10,516 shares of the financial services provider’s stock worth $1,443,000 after purchasing an additional 74 shares during the last quarter. Security National Bank of SO Dak raised its stake in shares of iShares Biotechnology ETF by 0.7% in the second quarter. Security National Bank of SO Dak now owns 10,461 shares of the financial services provider’s stock valued at $1,436,000 after acquiring an additional 75 shares during the last quarter. SPC Financial Inc. grew its position in iShares Biotechnology ETF by 2.4% during the 3rd quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock worth $475,000 after acquiring an additional 75 shares during the last quarter. Werba Rubin Papier Wealth Management increased its holdings in iShares Biotechnology ETF by 2.7% during the 3rd quarter. Werba Rubin Papier Wealth Management now owns 2,918 shares of the financial services provider’s stock valued at $425,000 after purchasing an additional 76 shares in the last quarter. Finally, Main Street Financial Solutions LLC raised its position in iShares Biotechnology ETF by 1.0% in the 2nd quarter. Main Street Financial Solutions LLC now owns 8,002 shares of the financial services provider’s stock valued at $1,098,000 after purchasing an additional 82 shares during the last quarter. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Price Performance

Shares of IBB stock traded down $0.21 during trading hours on Thursday, hitting $134.63. 77,551 shares of the company’s stock were exchanged, compared to its average volume of 1,444,948. The stock’s 50-day moving average is $143.82 and its 200-day moving average is $141.75. iShares Biotechnology ETF has a 52 week low of $117.28 and a 52 week high of $150.57.

iShares Biotechnology ETF Announces Dividend

The firm also recently announced a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were given a dividend of $0.2005 per share. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.